Ji'nan's generic drug conformance assessment was supported by the government with a maximum subsidy of 2 million yuan.
economic lead 2017-03-17 00:15
News (reporter Cao Fengqin) the Ji'nan municipal government issued a special policy to encourage the pharmaceutical production enterprises to accelerate To promote the consistency evaluation of the quality and efficacy of generic drugs (hereinafter referred to as "consistency evaluation"), to carry out consistent evaluation and to produce and settle accounts in Ji'nan, each variety is given 500 thousand -200 million yuan of support funds.
according to the policy, the variety (the specifications are considered as one variety, the same below) for the enterprise in vitro consistency evaluation study, each variety supports 1 million yuan; for the completion of in vitro conformance evaluation study, the varieties of bioequivalence test (BE test) in the body are approved, and each variety supports the fund 200. There are no more than 3 enterprises with the support of each enterprise in principle, but there are no restrictions on the number of BE trials in the first 3 varieties of the same breed.
for the first 3 varieties of the same varieties in China, the same kind of new drug production batch, one kind of new drug production batch, a one-time award of 1 million yuan; other varieties through the consistency evaluation, the same as the improved new drug production batch, a one-time award of 500 thousand yuan.
in addition, in the support of drug procurement and clinical medication support, municipal and grass-roots medical institutions are given priority to the use of the city through consistent evaluation of the drug.
Ji'nan is clear that the enterprise application support policy has been found to be in violation of the authenticity of the problem. All of them are credited to the credit management system, and the support funds have been recovered. The support funds obtained by enterprises must be specially used for the work of consistency evaluation, and they should not be occupied or misappropriated.
this special policy has been implemented since 2017 with a validity period of 5 years.